StockAnalyzer

Financial Analysis

DashboardSectorsComparablesScreenerUniverseMicrocapsAI 2nd OrderTheme MapEnergy & MaterialsMacroWatchlistCompareMi CarteraPortfolio

Recent

v0.1
APCO-R.BK$2.62+0.00%
Fair $2.62+0.0%

APCO-R.BK

Asian Phytoceuticals Public Company Limited

Consumer Defensive / Household & Personal ProductsThailand

$2.62

+0.00 (+0.00%)

Fairly Valued+0.0%Fair Value $2.62Fund rank 37/100 · Data gapFallback financials|
SA 44/C
F-Score: 6/9
Declining Revenue

FCF base 3Y

n/d

n/d CAGR · yield n/d

FCF base 5Y

n/d

n/d base · n/d expected

Precio de entrada

n/d

MOS 25% · confianza 25%

FCF escenarios

weak_data · normalized FCF $51.3M · quality 77.0/100

Data gap 37/100
Bear 5Yn/dn/d
Base 5Yn/dn/d
Bull 5Yn/dn/d
Return 0/100Downside 20/100Model quality 73/100Data QA 20/100

Ranking barato/determinista: CAGR esperado 5Y + downside bear + calidad del modelo + balance + capital allocation + data gate. No entra en buy-candidate si la data es débil o el CAGR 5Y no compensa.

Quality + valuation scorecard

SA Score

44/100

C

Piotroski

6/9

balance/quality

Valuation

50/100

+0.0% upside

5Y CAGR

+0.0%

50/100

Data QA

16/100

SEC 0%

Latest source: unknownPeriods: 4Warnings: 1unknown: 4
No SEC-backed annual rows; valuation uses fallback financial data. Insufficient audited annual history (<3 SEC-backed years); composite fair value and forward targets are disabled until manually verified. Revenue has declined for 2 consecutive years
Thesis & Journal · APCO-R.BKLocal privado en este navegador · Asian Phytoceuticals Public Company Limited
Plantilla tipo buy-side: tesis, bull/base/bear, catalizadores, riesgos, kill criteria y fecha de revisión. Esto no gasta GPT-5.5; luego lo usamos como contexto del memo.

Sin guardar todavía.

Market Cap

$1.6B

P/E

14.6x

↓

EV/EBITDA

16.7x

↑

ROE

9.9%

↑

Gross Margin

84.4%

↑

Debt/Equity

0.02

↓
52-Week Range$3
$6$6

TradingView lightweight chart

APCO-R.BK price, volumen y niveles de valoración

Último $6.274Periodo -17.4%
Fair value: $2.620

Price & Ratios

Absolute Values (Left Axis)

Ratios / Percentages (Right Axis)

Financial statement dashboard

Crecimiento, márgenes y provenance

2022–2025 · 3 años de histórico normalizado

Revenue CAGR

-7.2%

FCF CAGR

-19.9%

FCF margin

25.6%

FCF / Net income

0.93x

Latest source

Provider fallback

Margin decomposition

Último año: revenue $200.2M · net income $55.4M · FCF $51.3M

2022-FY → 2025-FY

Gross margin

84.4%+3.6% pts

Operating margin

28.0%-7.2% pts

Net margin

27.7%-4.6% pts

FCF margin

25.6%-14.3% pts
MetricTTM
2025
2024
2023
2022
Income Statement
Revenue$200.2M$200.2M$210.8M$292.8M$250.4M
Net Income$55.4M$55.4M$54.7M$107.5M$80.9M
EBITDA$91.0M$91.0M$90.3M$156.0M$124.3M
EPS0.090.090.090.180.13
Gross Margin84.4%84.4%80.6%80.4%80.9%
Operating Margin28.0%28.0%25.2%39.9%35.2%
Net Margin27.7%27.7%26.0%36.7%32.3%
Balance Sheet
Debt/Equity0.020.020.040.060.02
Current Ratio10.8210.82———
Cash Flow
Free Cash Flow$51.3M$51.3M$35.4M$120.0M$99.9M
Returns
ROE9.9%9.9%9.8%17.6%13.3%
Valuation
P/E14.5614.5669.7135.0536.93
EV/EBITDA16.7516.7541.8423.5723.49
P/B2.902.906.856.184.92
Growth & Yield
Revenue Growth-5.1%-5.1%-28.0%16.9%—
EPS Growth0.0%0.0%-49.7%32.7%—

Revenue, Net Income & Free Cash Flow ($B)

Margins (%)

Returns (%)

Leverage & Liquidity

Reverse DCF · market-implied EPS growthterminal P/E 15.0x · COE 10.0%

3Y implied EPS CAGR

37.2%

muy exigente

EPS terminal req.

$0.23

Spread vs growth

-37.2%

5Y implied EPS CAGR

25.6%

muy exigente

EPS terminal req.

$0.28

Spread vs growth

-25.6%

10Y implied EPS CAGR

17.5%

exigente

EPS terminal req.

$0.45

Spread vs growth

-17.5%

Qué te dice: cuánto EPS CAGR está descontando el precio si sales al múltiplo terminal indicado. Si el growth observado queda por debajo, el mercado está pidiendo una ejecución muy fina.

Return attribution · 1Y approxreconcilia total +0.0%

Total return

+0.0%

Start / end P/E

69.7x → 69.7x

EPS bridge

0.09 → 0.09

Residual

+0.0%

EPS growth+0.0%
Multiple rerating+0.0%
Dividend+0.0%
Residual / FX / buybacks / cross-term+0.0%

Simple additive decomposition: total return = EPS growth contribution + P/E multiple contribution + dividend contribution + explicit residual. The residual captures cross-terms, buybacks/share-count effects, FX, special dividends, data noise and methodology mismatch so the bridge always reconciles.